The fact
Following an initial trial targeting recurrences, this approach targets more severe forms.
This breakthrough could open new therapeutic perspectives for patients.
Click the link to read an article on the topic:
Following an initial trial targeting recurrences, this approach targets more severe forms.
This breakthrough could open new therapeutic perspectives for patients.